Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade · PMID 42321916
View analysis →A grade · PMID 42372741
View analysis →A grade · PMID 42382416
View analysis →A grade · PMID 42150584
View analysis →This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 89.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 100.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 89.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 100.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 89.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 100.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 89.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 100.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 89.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 100.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 88.8/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 84.2; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 88.8/100. Study design: 100.0; human relevance: 75.0; therapeutic relevance: 89.1; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 88.5/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 94.8; sample size: 40.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 87.9/100. Study design: 100.0; human relevance: 75.0; therapeutic relevance: 69.7; sample size: 90.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 87.8/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 69.1; sample size: 40.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 87.5/100. Study design: 100.0; human relevance: 75.0; therapeutic relevance: 70.2; sample size: 100.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 87.5/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 100.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 87.5/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 100.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 87.5/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 100.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 87.5/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 100.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 87.4/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 92.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 87.2/100. Study design: 100.0; human relevance: 75.0; therapeutic relevance: 66.2; sample size: 90.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 87.2/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 76.2; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 87.2/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 86.0; sample size: 30.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 86.8/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 89.2; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
